Product Information
MSDC-0602 is a novel antidiabetic drug that has been shown to inhibit the uptake of glucose by adipose tissues. This drug also stimulates mitochondrial function and increases the capacity of human liver cells to metabolize fatty acids. MSDC-0602 is currently in clinical trials for use in patients with hepatic steatosis, diabetes, or cancer. It is hoped that this drug will be effective against these diseases due to its ability to increase the uptake of glucose by liver cells and adipose tissues and its stimulation of mitochondrial function.
Chemical properties
Technical inquiry about: 3D-IVB81987 MSDC-0602
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
